Emcure Pharmaceuticals Gets Sebi's Go-Ahead To Float IPO
[email protected]20 Dec, 2021News
Bain Capital-backed Emcure Pharmaceuticals has received capital markets regulator Sebi's go-ahead to raise funds through an initial share-sale. The initial public offering (IPO) comprises fresh issuance of equity shares worth Rs 1,100 crore and offer of sale (OFS) of 18,168,356 equity shares by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).
Related Bookmarks
- Backyard Redesign
- Emcure Pharmaceuticals Receives Sebi Approval To Go Ahead With IPO Plans
- Gennova Biopharma Phase III Trials Of MRNA-Based Covid Vax To End In January
- hcracker
- High da Social Bookmarking Sites List
- hack de facebook
- Everything You Should Know About Green Energy
- Everything You Should Know About Array
- Read Information About Olive Tree - Info About Trees
- India's Position in the Indo- Pacific Strategy | India- Japan Relations
Recent Profiles
Keli Hemingway Counseling
Steroide kaufen
1gom
Bendix Woods
Jun88casino Top
Steven Hassanali
Titan Construction
Cochrane Laugesen
Multivoucherde
Thybo Bauer